Cover Image

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy

Claudio Mencacci,1 Guido Di Sciascio,2 Pablo Katz,3 Claudio Ripellino31Ospedale Fatebenefratelli, Milan, Italy; 2Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari, Italy; 3CSD Medical Research Srl, Milan, ItalyBackground: Depression has a lifetime prevalence of 10%–25...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mencacci C (Author), Di Sciascio G (Author), Katz P (Author), Ripellino C (Author)
Format:	Book
Published:	Dove Medical Press, 2013-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia
by: Mencacci C, et al.
Published: (2013)

Fabrication and Characterization of Fast-Dissolving Films Containing Escitalopram/Quetiapine for the Treatment of Major Depressive Disorder
by: Manal E. Alkahtani, et al.
Published: (2021)

Treatment of alcohol dependence in patients with co-morbid major depressive disorder - predictors for the outcomes with memantine and escitalopram medication
by: Lönnqvist Jouko, et al.
Published: (2008)

A Study about Escitalopram Versus Citalopram in the Treatment of Depressive Disorders
by: Jasim M. Shindi, et al.
Published: (2015)

The impact of CYP2C19 genotypes on steady-state plasma concentration of escitalopram in South Indian population with Major Depressive Disorder
by: B. Jeevan Kumar, et al.
Published: (2024)

Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders
by: Saad S. Alkhowaiter, et al.
Published: (2023)

Healthcare Resource Consumption and Related Costs of Patients Estimated with Treatment-Resistant Depression in Italy
by: Perrone V, et al.
Published: (2021)

Comparison between Escitalopram and Pregabalin for Generalized Anxiety Disorder Treatment
by: Muhammad Shoaib Zafar, et al.
Published: (2022)

Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram
by: Jung YS, et al.
Published: (2024)

Escitalopram Induced Drug Eruption
by: Bhatia M S
Published: (2004)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
by: Stacey L. Aldrich, et al.
Published: (2019)

Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
by: Soraia Silva, et al.
Published: (2021)

Escitalopram-induced skin rash: Dermatitis medicamentosa
by: Sangha M Godi, et al.
Published: (2022)

HPLC determination of Escitalopram in tablet dosage forms
by: Stefan Balkanski
Published: (2022)

A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility
by: Gizzo S, et al.
Published: (2016)

Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review
by: van Marwijk Harm WJ, et al.
Published: (2010)

Escitalopram Personalized Dosing: A Population Pharmacokinetics Repository Method
by: Liu X, et al.
Published: (2023)

A Síndrome do QT Longo Associada ao uso de Citalopram e Escitalopram / The Long QT Syndrome Associated to Citalopram and Escitalopram
by: Filipe Santos Falani, et al.
Published: (2016)

Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions
by: Ahn, Hyewon
Published: (2011)

Is the bradycardia caused by cetirizine only or the interaction of escitalopram and cetirizine?
by: Hsiu-Hui Chiu, et al.
Published: (2019)

Major Depressive Disorder Cognitive and Neurobiological Mechanisms
Published: (2015)

Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder
by: Yan T, et al.
Published: (2020)

Major depression disorder - etiology and treatment
by: Paulina Czuchryta, et al.
Published: (2023)

Major depressive disorder in detention officers
by: Sheila Nascimento Santos, et al.
Published: (2021)

Dysthymia and Major Depressive Disorders Compared
by: J Gordon Millichap
Published: (1994)

Acupuncture for Major Depressive Disorder A Systematic Review
by: Sorbero, Melony E.
Published: (2015)

Comparative efficacy and safety of escitalopram versus desvenlafaxine in postmenopausal women with depression and anxiety: A randomized, open-label, comparative trial
by: Sonia Shinde Mahajan, et al.
Published: (2019)

Perospirone augmentation of escitalopram in the treatment of an adolescent sophophobia (fear of learning) patient
by: Kensuke Miyazaki
Published: (2022)

Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with Escitalopram
by: Shreaya Chakroborty, et al.
Published: (2017)

Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder
by: Roberto F. Almeida, et al.
Published: (2021)

Cost-effectiveness analysis of genotype-guided optimization of major depression treatment in Qatar
by: Dina Abushanab, et al.
Published: (2024)

Relationship between Comorbidity of Cluster Personality Disorders with Major Depression Disorder and Depression Relapse
by: Shima Tamanaei-Far, et al.
Published: (2008)

Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX‐2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis
by: Toshinori Shirata, et al.
Published: (2023)

Effect of an Educational Booklet on Knowledge and Attitude Regarding Major Depressive Disorder in Medical Students in Delhi
by: Medha Goyal, et al.
Published: (2013)

Effect of an Educational Booklet on Knowledge and Attitude Regarding Major Depressive Disorder in Medical Students in Delhi
by: Medha Goyal, et al.
Published: (2013)

Costs of major depression covered / not covered in British Columbia, Canada
by: Sonya Cressman, et al.
Published: (2023)

The Effect of Dignity Therapy on Perceived Dignity in Patients With Major Depression Disorder
by: Vaghee, et al.
Published: (2016)

A cost-of-illness study of spina bifida in Italy
by: Colombo GL, et al.
Published: (2013)

Major depressive disorder in chronic heart failure patients: Does silent cerebral infarction cause major depressive disorder in this patient population?
by: Güliz Kozdağ, et al.
Published: (2015)

Psychosocial working conditions and major depression or depressive disorders: Review of studies
by: Dorota Żołnierczyk-Zreda, et al.
Published: (2018)